section name header

Table 92-2

Antimicrobial Therapy for Infections Involving Commonly Encountered Anaerobic Gram-Negative Rods

Category 1 (Nearly Always Active)Category 2 (Usually Active)Category 3 (Variable Resistance)Category 4 (Resistance)
Carbapenems (imipenem, meropenem, doripenem)

Metronidazolea

β-Lactam/β-lactamase inhibitor combinations (ampicillin/sulbactam, ticarcillin/clavulanic acid, piperacillin/tazobactam)

Chloramphenicolb

Tigecycline

High-dose anti-pseudomonal penicillins

Cephamycins (cefoxitin, cefotetan)

Clindamycin

Penicillins

Cephalosporins

Tetracycline

Vancomycin

Erythromycin

Moxifloxacin

Aminoglycosides

Monobactams

Trimethoprim-sulfamethoxazole

aUsually needs to be given in combination with aerobic bacterial coverage. For infections originating below the diaphragm, aerobic gram-negative coverage is essential. For infections from an oral source, aerobic gram-positive coverage is added. Metronidazole also is not active against Actinomyces, Propionibacterium, or other gram-positive non-spore-forming bacilli (e.g., Eubacterium, Bifidobacterium) and is unreliable against peptostreptococci.

bDespite excellent in vitro activity against all clinically important anaerobes, this drug is less desirable than other active drugs because of documented clinical failures.